86 related articles for article (PubMed ID: 32490817)
1. Onset of Schamberg Disease and Resolution of Alopecia Areata During Treatment of Atopic Dermatitis With Dupilumab.
Szekely S; Vaccari D; Salmaso R; Belloni-Fortina A; Alaibac M
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):65-66. PubMed ID: 32490817
[No Abstract] [Full Text] [Related]
2. Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children.
Fang H; Zhang F; Lin W; Jiang Y; Liu Q; Yang D
Front Immunol; 2024; 15():1395288. PubMed ID: 38903518
[TBL] [Abstract][Full Text] [Related]
3. Potential Indications of Dupilumab in Th-2 Inflammatory Disease.
Ilaria P; Nevena S; Ersilia T; Nicoletta B; Federica T; Di Fraia M; Agniezska D; Concetta P
Rev Recent Clin Trials; 2024; 19(1):53-61. PubMed ID: 38141197
[TBL] [Abstract][Full Text] [Related]
4. Persistence of mature dendritic cells, T
Bangert C; Rindler K; Krausgruber T; Alkon N; Thaler FM; Kurz H; Ayub T; Demirtas D; Fortelny N; Vorstandlechner V; Bauer WM; Quint T; Mildner M; Jonak C; Elbe-Bürger A; Griss J; Bock C; Brunner PM
Sci Immunol; 2021 Jan; 6(55):. PubMed ID: 33483337
[TBL] [Abstract][Full Text] [Related]
5. A case of atopic dermatitis with self-healing acute diffuse and total alopecia during nemolizumab treatment.
Suehiro M; Tanaka A
J Dermatol; 2024 Apr; 51(4):e123-e124. PubMed ID: 37929306
[No Abstract] [Full Text] [Related]
6. Prurigo-like atopic dermatitis in a child with CARD11-associated severe combined immunodeficiency successfully treated with dupilumab.
Gualdi G; Lougaris V; Amerio P; Petruzzellis A; Parodi A; Burlando M
Pediatr Dermatol; 2024; 41(1):158-159. PubMed ID: 37888582
[TBL] [Abstract][Full Text] [Related]
7. Psoriasis-like lesions in an atopic dermatitis patient possibly associated with nemolizumab treatment.
Masuda T; Yonekura S; Kataoka K; Mizoguchi K; Hirata M; Fujimoto M; Nakajima S; Kabashima K
J Dermatol; 2024 Jun; 51(6):e193-e195. PubMed ID: 38149402
[No Abstract] [Full Text] [Related]
8. Erythema induratum of Bazin during successful treatment of atopic dermatitis with dupilumab.
Zhou C; Su T; Wang Y; Hou Y; Yin Z; Xia J
Australas J Dermatol; 2024 May; 65(3):e69-e71. PubMed ID: 38421820
[No Abstract] [Full Text] [Related]
9. Eosinophilic annular erythema-like adult-onset atopic dermatitis successfully treated with dupilumab.
Liaw TY
Ital J Dermatol Venerol; 2024 Apr; 159(2):203-205. PubMed ID: 38650501
[No Abstract] [Full Text] [Related]
10. Biological Therapies for Pediatric Atopic Dermatitis - A Review.
Milano G; Forestieri S; Tedeschi M; Licari A; Brazzelli V; Marseglia GL
Curr Pediatr Rev; 2024; 20(3):240-252. PubMed ID: 37702168
[TBL] [Abstract][Full Text] [Related]
11. Atopic dermatitis treated safely with dupilumab during pregnancy and lactation: A case series of four patients.
Hong N; Park SY; Kook HD; Lee DH; Jung HJ; Park MY; Ahn J
Australas J Dermatol; 2024 Jun; 65(4):e100-e103. PubMed ID: 38509808
[No Abstract] [Full Text] [Related]
12. IgE levels in patients with atopic dermatitis steadily decrease during treatment with dupilumab regardless of dose interval.
Dekkers C; van der Wal MM; van den Noort L; Bakker DS; de Bruin-Weller M; van Wijk F
Clin Exp Allergy; 2023 Nov; 53(11):1222-1225. PubMed ID: 37700483
[No Abstract] [Full Text] [Related]
13. Mid-Term Efficacy of Dupilumab in Children Aged≥36 Months to <12 Years With Atopic Dermatitis: A Case Series.
Melgosa Ramos FJ; Díaz Corpas T; Martín Jiménez S; Mateu Puchades A
Actas Dermosifiliogr; 2024 Jun; 115(6):625-627. PubMed ID: 38373609
[No Abstract] [Full Text] [Related]
14. Nemolizumab reduces itch and improves other signs of atopic dermatitis in children aged 6-12 years.
Br J Dermatol; 2023 Dec; 190(1):e2. PubMed ID: 38124526
[No Abstract] [Full Text] [Related]
15. Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report.
Novielli D; Foti C; Principi M; Mortato E; Romita P; Dell'Aquila P; Di Leo A; Ambrogio F
J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):e8-e10. PubMed ID: 37478286
[No Abstract] [Full Text] [Related]
16. Effectiveness of Dupilumab in the treatment of both atopic dermatitis and alopecia universalis.
Call JE; Sahni S; Zug KA
Clin Case Rep; 2020 Aug; 8(8):1337-1339. PubMed ID: 32884748
[TBL] [Abstract][Full Text] [Related]
17. The differences in the count of B lymphocytes in atopic dermatitis patients with and without dupilumab therapy and in healthy subjects in pollen season and out of pollen season.
Čelakovská J; Čermáková E; Andrýs C; Boudkova P; Krejsek J
J Dermatolog Treat; 2024 Dec; 35(1):2290360. PubMed ID: 38213263
[No Abstract] [Full Text] [Related]
18. Effectiveness of dupilumab in the treatment of alopecia areata in patients with concurrent atopic dermatitis: a real-life retrospective study.
Tavoletti G; Valtellini L; Mattioli MA; Chiei-Gallo A; Barbareschi M; Marzano AV; Ferrucci SM
Int J Dermatol; 2024 Jun; ():. PubMed ID: 38840319
[No Abstract] [Full Text] [Related]
19. Machine learning analysis of pretreatment skin biopsies predicts nonresponse to dupilumab in patients with eczematous dermatitis.
Murphy MJ; Hwang E; Singh K; Lee T; Cohen JM; Damsky W
Br J Dermatol; 2023 Dec; 190(1):132-134. PubMed ID: 37818837
[No Abstract] [Full Text] [Related]
20. Corneal Transplant Rejection and Alopecia Areata Universalis in a Patient With Severe Atopic Dermatitis on Dupilumab.
Lopez-Bernal T; Mazaira Fernández M; Vargas-Machuca Salido I; Aranegui B
Actas Dermosifiliogr; 2023 Dec; ():. PubMed ID: 38159837
[No Abstract] [Full Text] [Related]
[Next] [New Search]
